For acute COVID-19 patients with the critical disease, tetramer+CD8+ T cells lack polyfunctional cytokine production, and exhibit high expression of inhibitory receptors and gene expression profiles that limit T cell re-activation and migration (29). This evidence concerns the gene CD8A and COVID-19.